Testing for type-specific antibody to herpes simplex virus - Implications for clinical practice

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue TOPIC T3, 2000, Pages 9-13

  Cowan, F M ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

CLINICAL PRACTICE; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOBLOTTING; VIRUS TRANSMISSION;

EID: 0034075366     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.suppl_4.9     Document Type: Conference Paper

References (17)

1. Koutsky, L. A., Ashley, R. L., Holmes, K. K., Stevens, C. E., Critchlow, C. W., Kiviat, N. et al. (1990). The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sexually Transmitted Diseases 17, 90-4.
2. Ashley, R. L. (1993). Laboratory techniques in the diagnosis of herpes simplex infection. Genitourinary Medicine 69, 174-83.
3. Ho, D. W., Field, P. R., Sjogren-Jansson, E., Jeansson, S. & Cunningham, A. L. (1992). Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). Journal of Virological Methods 36, 249-64.
4. Ho, D. W., Field, P. R., Irving, W. L., Packham, D. R. & Cunningham, A. L. (1993). Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. Journal of Clinical Microbiology 31, 3157-64.
5. Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K. et al. (1997). Herpes simplex virus type 2 in the United States, 1976 to 1994. New England Journal of Medicine 337, 1105-11.
6. Cowan, F. M., Johnson, A. M., Ashley, R., Corey, L. & Mindel, A. (1994). Antibody to herpes simplex virus type 2 as a serological marker of sexual lifestyle in populations. British Medical Journal 309, 1325-9.
7. Forsgren, M., Skoog, E., Jeansson, S., Olofsson, S. & Giesecke, J. (1994). Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969,1983 and 1989: implications for STD epidemiology. International Journal of STD and AIDS 5, 113-6.
8. Wagner, H. U., Van Dyck, E., Roggen, E., Nunn, A. J., Kamali, A, Schmid, D. S. et al. (1994). Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. International Journal of STD and AIDS 5, 332-7.
9. Cunningham, A. L., Lee, F. K., Ho, D. W., Field, P. R., Law, C. L., Packham, D. R. et al. (1993). Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Medical Journal of Australia 158, 525-8.
10. Brown, Z. A., Selke, S., Zeh, J., Kopelman,J., Maslow, A., Ashley, R. L. et al. (1997). The acquisition of herpes simplex virus during pregnancy. New England Journal of Medicine 337, 509-15.
11. Mertz, G. J., Benedetti, J., Ashley, R., Selke, S. A. & Corey, L. (1992). Risk factors for the sexual transmission of genital herpes. Annals of Internal Medicine 116, 197-202.
12. Langenberg, A. G. M., Corey, R. L., Ashley, R. L., Leong, W. P. & Straus, S. E. (1999). A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. New England Journal of Medicine 341, 1432-8.
13. Fleming, D. T. & Wasserheit, J. N. (1999). From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV. Sexually Transmitted Infections 75, 3-17.
14. Benedetti, J., Corey, L. & Ashley, R. (1994). Recurrence rates in genital herpes after symptomatic first-episode infection. Annals of Internal Medicine 121, 847-54.
15. Mindel, A. (1998). Genital herpes - how much of a public-health problem? Lancet 351, Suppl. 3, 16-8.
16. White, P. J. & Garnett, G. P. (1999). Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2. Sexually Transmitted Infections 75, 49-54.
17. Corey, L. (1998). Raising the conciousness for identifying and controlling viral STDs: fears and frustrations - Thomas Parran Award Lecture. Sexually Transmitted Diseases 25, 58-69.